Bibliography
Export 2 results:
Filters: Author is Schrezenmeier, Hubert [Clear All Filters]
Successful use of eculizumab for treatment of an acute hemolytic reaction after ABO-incompatible red blood cell transfusion. Transfusion//Transfusion. 2015;55(3):605-10.
A new blood group antigen is defined by anti-CD59, detected in a CD59-deficient patient. Transfusion//Transfusion. 2014;54(7):1817-22.